Pharma Surge

Pharma Surge

🌍·12h agoResearch

<scp> <i>CYP2C19</i> </scp> c. <scp>681G</scp> &gt;A Is not in Complete Linkage Disequilibrium With c.332‐ <scp>23A</scp> &gt;G: Implications for Pharmacogenetic Testing

Publisher

C
Crossref

Global

This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.

Read original

At a glance

Publisher
Crossref
Region
Global
Scope
Research
Published
July 31, 2026
Language
EN

In-platform summary, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Source route

Continue on doi.org

Leave the platform to read the original full article on the publisher site.

Source: Crossref

Scope: Research

Open original article
<scp> <i>CYP2C19</i> </scp> c. <scp>681G</scp> &gt;A Is not in Complete Linkage Disequilibrium With c.332‐ <scp>23A</scp> &gt;G: Implications for Pharmacogenetic Testing | Pharma Surge